Beremagene Geperpavec: First Approval.
- Published in:
- Drugs, 2023, v. 83, n. 12, p. 1131, doi. 10.1007/s40265-023-01921-5
- By:
- Publication type:
- Article
Works matching IS 00126667 AND DT 2023 AND VI 83 AND IP 12
Results: 9
1
2
Correction to: Fenfluramine: A Review in Dravet and Lennox-Gastaut Syndromes.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
3
Fezolinetant: First Approval.
- Published in:
- Drugs, 2023, v. 83, n. 12, p. 1137, doi. 10.1007/s40265-023-01917-1
- By:
- Publication type:
- Article
4
Diabetes of the Exocrine Pancreas: Implications for Pharmacological Management.
- Published in:
- Drugs, 2023, v. 83, n. 12, p. 1077, doi. 10.1007/s40265-023-01913-5
- By:
- Publication type:
- Article
5
Efbemalenograstim Alfa: First Approval.
- Published in:
- Drugs, 2023, v. 83, n. 12, p. 1125, doi. 10.1007/s40265-023-01911-7
- By:
- Publication type:
- Article
6
New Opportunities to Individualize Frontline Therapy in Advanced Stages of Hepatocellular Carcinoma.
- Published in:
- Drugs, 2023, v. 83, n. 12, p. 1091, doi. 10.1007/s40265-023-01907-3
- By:
- Publication type:
- Article
7
Pharmacologic Management of Cancer-Related Pain in Pregnant Patients.
- Published in:
- Drugs, 2023, v. 83, n. 12, p. 1067, doi. 10.1007/s40265-023-01906-4
- By:
- Publication type:
- Article
8
Omalizumab in Severe Asthma: Effect on Oral Corticosteroid Exposure and Remodeling. A Randomized Open-Label Parallel Study.
- Published in:
- Drugs, 2023, v. 83, n. 12, p. 1111, doi. 10.1007/s40265-023-01905-5
- By:
- Publication type:
- Article
9
Correction to: Recent Human Papillomavirus Vaccination is Associated with a Lower Risk of COVID-19: A US Database Cohort Study.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice